138 results on '"Bhateja, Priyanka"'
Search Results
2. Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort
3. Effectiveness of Nasolacrimal SCC Treatments and Promising Role of Chemo‐Induction: A Case Report and Systematic Review.
4. Immunoprofiles and Oncologic Outcomes of 15 Patients with Androgen Receptor-Positive Salivary Duct Carcinoma
5. Palliative Quad Shot Radiation Therapy with or without Concurrent Immune Checkpoint Inhibition for Head and Neck Cancer
6. Scalp Irradiation with 3D-Milled Bolus: Initial Dosimetric and Clinical Experience
7. Audiological Outcomes of Weekly vs. Triweekly Cisplatin in Head and Neck Cancer with Cochlear-Sparing Intensity-Modulated Radiation Therapy.
8. Outcomes of definitive local therapy with intensity‐modulated radiation therapy in elderly patients ≥70 years with HPV‐associated oropharyngeal cancer
9. KMT2D Mutation Is Associated With Poor Prognosis in Non–Small-Cell Lung Cancer
10. Patient‐reported outcomes in immunotherapy for head and neck cancer
11. Phase I study of the combination of quinacrine and erlotinib in patients with locally advanced or metastatic non small cell lung cancer
12. The use of plasma circulating tumor DNA for early detection of oligometastatic disease in HPV positive oropharyngeal squamous cell carcinoma
13. Supplementary Table from Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
14. Supplementary Figure from Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
15. Impact of Tobacco, Marijuana, and Alcohol use on Overall Survival in Recurrent Metastatic head and neck Cancer Patients Treated with Immune Checkpoint Inhibitors
16. Severe late dysphagia and cause of death after concurrent chemoradiation for larynx cancer in patients eligible for RTOG 91-11
17. Association between Tumor Microbiome and Hypoxia across Anatomic Subsites of Head and Neck Cancers
18. Fractional Rectified Linear Unit Activation Function and Its Variants
19. T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma
20. 558: Impact of Immunotherapy on Overall Survival in Anaplastic Thyroid Cancer
21. Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
22. 837 Preliminary insights into the impact of tumor microbiome in head and neck squamous cell carcinoma
23. Impact of feeding tube choice on severe late dysphagia after definitive chemoradiotherapy for human papillomavirus–negative head and neck cancer
24. Postoperative Complications in Patients With Unrecognized Obesity Hypoventilation Syndrome Undergoing Elective Noncardiac Surgery
25. Treatment Outcomes of Head and Neck Cancer Patients in the Elderly Receiving Different Chemoradiation Combinations: A Single-Center Experience
26. Efficacy of concurrent cetuximab (CTX) and nivolumab (NIVO) in previously untreated recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
27. Use of cetuximab added to weekly chemotherapy to improve progression-free survival in patients with recurrent metastatic head and neck squamous cell carcinoma after progression on immune checkpoint inhibitors.
28. Expansion cohort validation of a clinical predictive model for head and neck cancer survival in patients treated with immune checkpoint inhibitors.
29. Evaluation, Prediction and Treatment of Radiation- Induced Normal Tissue Damage in Head and Neck Cancer
30. Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II Study
31. Identification of Clinical and Socioeconomic Predictors of Adjuvant Therapy after Trans-Oral Robotic Surgery in Patients with Oropharyngeal Squamous Cell Carcinoma
32. ACUTE NECROTIZING ENCEPHALOPATHY OF CHILDHOOD: A CASE REPORT
33. Window-of-opportunity trial of nivolumab with or without the IDO inhibitor BMS-986205 in patients with resectable squamous cell carcinoma of the head and neck (SCCHN).
34. Obesity and Metabolic Dysregulation in Childhood: A Review
35. Potential Armamentarium to Contain COVID-19 Pandemic in Developing Countries: Be Prepared and Act Timely!
36. A detailed smoking history and determination of MYC status predict response to checkpoint inhibitors in advanced non-small cell lung cancer
37. The Hedgehog Signaling Pathway: A Viable Target in Breast Cancer?
38. Re-evaluating the neutrophil-to-lymphocyte ratio: Machine learning-based variable selection for predicting survival at twelve months in late-stage cancer patients receiving immunotherapy.
39. Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer
40. Emerging Risk Factors and Prevention of Perioperative Pulmonary Complications
41. Frequency of NOTCH pathway mutation in primary tumor of SCLC compared to metastatic biopsies and association with better survival.
42. Triple “A” syndrome presenting as recurrent chronic sinusitis with pneumonia, septic shock and meningoencephalitis in a 13 years old boy
43. Phase I study of the combination of quinacrine and erlotinib in patients with locally advanced or metastatic non small cell lung cancer
44. Association of MLL2 mutation positive non-small cell lung cancer with prognosis.
45. Retinoblastoma mutation to predict poor outcomes in non-small cell lung cancer (NSCLC).
46. Genomic profiling of circulating tumor DNA in small cell lung cancer: comparison of relapsed disease to initial tumor biopsies.
47. Afatinib plus chemotherapy versus chemotherapy alone after progression on afatinib: new insights on old question?
48. Impaired vocal cord mobility in T2N0 glottic carcinoma: Suboptimal local control with Radiation alone
49. Clinical predictive factors of overall survival and locoregional failure in advanced laryngeal cancer treated with definitive chemoradiation.
50. Whole exome sequencing of sinonasal cancers.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.